Daniel M Aebersold
Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial.
Beck M, Li Q, Sumila M, Zaugg K, Guckenberger M, Ost P, Bosetti D, Reuter C, Gomez S, Khanfir K, Aebersold D, Ghadjar P, Schär C, Hayoz S, Papachristofilou A, Sassowsky M, Schär S, Mathier E, Halter M, Zwahlen D, Hölscher T, Arnold W, Polat B, Hildebrandt G, Müller A, Putora P, Pra A. Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial. Int J Radiat Oncol Biol Phys 2022; 113:80-91.
Jan 3, 2022Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial.
Jan 3, 2022Int J Radiat Oncol Biol Phys 2022; 113:80-91
Beck Marcus, Li Qiyu, Sumila Marcin, Zaugg Kathrin, Guckenberger Matthias, Ost Piet, Bosetti Davide G, Reuter Christiane, Gomez Silvia, Khanfir Kaouthar, Aebersold Daniel M, Ghadjar Pirus, Schär Corinne, Hayoz Stefanie, Papachristofilou Alexandros, Sassowsky Manfred, Schär Sämi, Mathier Etienne, Halter Matthias, Zwahlen Daniel R, Hölscher Tobias, Arnold Winfried, Polat Bülent, Hildebrandt Guido, Müller Arndt-Christian, Putora Paul Martin, Pra Alan Dal
Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial
Ghadjar P, Zaugg K, Guckenberger M, Ost P, Reuter C, Bosetti D, Kaouthar K, Gomez S, Wust P, Thalmann G, Aebersold D, Sumila M, Schär C, Hayoz S, Bernhard J, Zwahlen D, Hölscher T, Gut P, Polat B, Hildebrandt G, Müller A, Plasswilm L, Papachristofilou A, Swiss Group for Clinical Cancer Research (SAKK). Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial. Eur Urol 2021; 80:306-315.
Jun 14, 2021Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial
Jun 14, 2021Eur Urol 2021; 80:306-315
Ghadjar Pirus, Zaugg Kathrin, Guckenberger Matthias, Ost Piet, Reuter Christiane, Bosetti Davide G, Kaouthar Khanfir, Gomez Silvia, Wust Peter, Thalmann George N, Aebersold Daniel M, Sumila Marcin, Schär Corinne, Hayoz Stefanie, Bernhard Jürg, Zwahlen Daniel R, Hölscher Tobias, Gut Philipp, Polat Bülent, Hildebrandt Guido, Müller Arndt-Christian, Plasswilm Ludwig, Papachristofilou Alexandros, Swiss Group for Clinical Cancer Research (SAKK)
A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives
Achard V, Matzinger O, Peguret N, Pesce G, Putora P, Reuter C, Richetti A, Vees H, Vrieling C, Zaugg K, Zimmermann F, Zwahlen D, Tsoutsou P, Kaouthar K, Huck C, Herrmann E, Aebersold D, Allal A, Andratschke N, Baumert B, Beer K, Betz M, Breuneval T, Bodis S, De Bari B, Förster R, Franzetti-Pellanda A, Guckenberger M, Zilli T. A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives. Radiother Oncol 2020; 150:1-3.
Jun 6, 2020A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives
Jun 6, 2020Radiother Oncol 2020; 150:1-3
Achard Vérane, Matzinger Oscar, Peguret Nicolas, Pesce Gianfranco, Putora Paul Martin, Reuter Christiane, Richetti Antonella, Vees Hansjörg, Vrieling Conny, Zaugg Kathrin, Zimmermann Frank, Zwahlen Daniel R, Tsoutsou Pelagia, Kaouthar Khanfir, Huck Constance, Herrmann Evelyn, Aebersold Daniel M, Allal Abdelkarim S, Andratschke Nicolaus, Baumert Brigitta G, Beer Karl T, Betz Michael, Breuneval Thomas, Bodis Stephan, De Bari Berardino, Förster Robert, Franzetti-Pellanda Alessandra, Guckenberger Matthias, Zilli Thomas
Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer-A Multicenter Study
Elicin O, Giger R, Spielmann T, Prestwich R, Riesterer O, Kaydıhan N, Shelan M, Guckenberger M, Ozsahin M, Anschuetz L, Adam L, Henke G, Studer G, Zimmermann F, Caparrotti F, Aebersold D, Oehler C, Ermiş E, Şen M. Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer-A Multicenter Study. Front Oncol 2019; 9:932.
Sep 20, 2019Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer-A Multicenter Study
Sep 20, 2019Front Oncol 2019; 9:932
Elicin Olgun, Giger Roland, Spielmann Thierry, Prestwich Robin J D, Riesterer Oliver, Kaydıhan Nuri, Shelan Mohamed, Guckenberger Matthias, Ozsahin Mahmut, Anschuetz Lukas, Adam Lukas, Henke Guido, Studer Gabriela, Zimmermann Frank, Caparrotti Francesca, Aebersold Daniel M, Oehler Christoph, Ermiş Ekin, Şen Mehmet
[Modern Treatment Concepts in Radiation Oncology]
Plasswilm L, Studer G, Aebersold D, Zwahlen D. [Modern Treatment Concepts in Radiation Oncology]. Ther Umsch 2019; 76:209-218.
Sep 1, 2019[Modern Treatment Concepts in Radiation Oncology]
Sep 1, 2019Ther Umsch 2019; 76:209-218
Plasswilm Ludwig, Studer Gabriela, Aebersold Daniel M, Zwahlen Daniel R
Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer
Hoyle A, Aebersold D, Jones R, Matheson D, Millman R, Mason M, Ritchie A, Russell M, Douis H, Parmar M, Sydes M, Clarke N, Gillessen Sommer S, Ingleby F, Ali A, James N, Cook A, Parker C, de Bono J, Attard G, Chowdhury S, Cross W, Dearnaley D, Brawley C, Gilson C, STAMPEDE Investigators. Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer. Eur Urol 2019; 76:719-728.
Aug 23, 2019Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer
Aug 23, 2019Eur Urol 2019; 76:719-728
Hoyle Alex P, Aebersold Daniel M, Jones Rob J, Matheson David, Millman Robin, Mason Malcolm D, Ritchie Alastair W S, Russell Martin, Douis Hassan, Parmar Mahesh K B, Sydes Matthew R, Clarke Noel W, Gillessen Sommer Silke, Ingleby Fiona, Ali Adnan, James Nicholas D, Cook Adrian, Parker Christopher C, de Bono Johann S, Attard Gerhardt, Chowdhury Simon, Cross William R, Dearnaley David P, Brawley Christopher D, Gilson Clare, STAMPEDE Investigators
Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17/04 trial
Riesterer O, Krayenbuehl J, Weder W, Sabrina Stark L, Zimmermann F, Nackaerts K, Zwahlen D, Mahmut Ozsahin E, Plasswilm L, Aebersold D, Xyrafas A, Stahel R, Ciernik I, Swiss Group for Clinical Cancer Research (SAKK). Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17/04 trial. Radiother Oncol 2019; 138:121-125.
Jun 25, 2019Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17/04 trial
Jun 25, 2019Radiother Oncol 2019; 138:121-125
Riesterer Oliver, Krayenbuehl Jerome, Weder Walter, Sabrina Stark L, Zimmermann Frank, Nackaerts Kristiaan, Zwahlen Daniel R, Mahmut Ozsahin E, Plasswilm Ludwig, Aebersold Daniel M, Xyrafas Alexandros, Stahel Rolf A, Ciernik I Frank, Swiss Group for Clinical Cancer Research (SAKK)
Comparison of contemporary staging systems for oropharynx cancer in a surgically treated multi-institutional cohort.
Elicin O, Broglie M, Fankhauser N, Stoeckli S, Pasche P, Reinhard A, Bongiovanni M, Huber G, Morand G, Soltermann A, Arnold A, Dettmer M, Arnoux A, Stauffer E, Espeli V, Martucci F, Aebersold D, Giger R. Comparison of contemporary staging systems for oropharynx cancer in a surgically treated multi-institutional cohort. Head Neck 2018; 41:1395-1402.
Dec 28, 2018Comparison of contemporary staging systems for oropharynx cancer in a surgically treated multi-institutional cohort.
Dec 28, 2018Head Neck 2018; 41:1395-1402
Elicin Olgun, Broglie Martina A, Fankhauser Niklaus, Stoeckli Sandro J, Pasche Philippe, Reinhard Antoine, Bongiovanni Massimo, Huber Gerhard F, Morand Grégoire B, Soltermann Alex, Arnold Andreas, Dettmer Matthias S, Arnoux Andre, Stauffer Edouard, Espeli Vittoria, Martucci Francesco, Aebersold Daniel M, Giger Roland
A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC)
Panje C, Lupatsch J, Plasswilm L, Aebersold D, Siano M, Gautschi O, Schwenkglenks M, Matter-Walstra K, Dedes K, Swiss Group for Clinical Cancer Research (SAKK). A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC). Radiother Oncol 2018; 129:257-263.
Aug 10, 2018A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC)
Aug 10, 2018Radiother Oncol 2018; 129:257-263
Panje Cédric, Lupatsch Judith E, Plasswilm Ludwig, Aebersold Daniel M, Siano Marco, Gautschi Oliver, Schwenkglenks Matthias, Matter-Walstra Klazien, Dedes Konstantin J, Swiss Group for Clinical Cancer Research (SAKK)
Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective study
Cihoric N, Aebersold D, Yojena C, Soldatovic I, Shelan M, Scherz A, Novak U, Glatzer M, Vlaskou Badra E, Tsikkinis A, Lössl K. Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective study. Radiat Oncol 2017; 12:202.
Dec 22, 2017Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective study
Dec 22, 2017Radiat Oncol 2017; 12:202
Cihoric Nikola, Aebersold Daniel M, Yojena Chittazhathu Kurian Kuruvilla, Soldatovic Ivan, Shelan Mohamed, Scherz Amina, Novak Urban, Glatzer Markus, Vlaskou Badra Eugenia, Tsikkinis Alexandros, Lössl Kristina
Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10
Ghadjar P, Thalmann G, Aebersold D, Wust P, Biaggi Rudolf C, Dal Pra A, Schär C, Papachristofilou A, Putora P, Müller A, Hildebrandt G, Polat B, Gut P, Hölscher T, Stein J, Zwahlen D, Bernhard J, Hayoz S, Swiss Group for Clinical Cancer Research (SAKK). Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10. Radiother Oncol 2017
Nov 3, 2017Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10
Nov 3, 2017Radiother Oncol 2017
Ghadjar Pirus, Thalmann George N, Aebersold Daniel M, Wust Peter, Biaggi Rudolf Christine, Dal Pra Alan, Schär Corinne, Papachristofilou Alexandros, Putora Paul Martin, Müller Arndt-Christian, Hildebrandt Guido, Polat Bülent, Gut Philipp, Hölscher Tobias, Stein Jürgen, Zwahlen Daniel R, Bernhard Jürg, Hayoz Stefanie, Swiss Group for Clinical Cancer Research (SAKK)
Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer
Ghadjar P, Kranzbühler H, Najafi Y, Ost P, Azinwi N, Reuter C, Bodis S, Kaouthar K, Budach V, Aebersold D, Thalmann G, Sumila M, Biaggi-Rudolf C, Stalder L, Hayoz S, Genitsch V, Zwahlen D, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller A, Putora P, Papachristofilou A, Swiss Group for Clinical Cancer Research (SAKK). Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer. BJU Int 2017; 120:E45-E51.
Jan 19, 2017Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer
Jan 19, 2017BJU Int 2017; 120:E45-E51
Ghadjar Pirus, Kranzbühler Helmut, Najafi Yousef, Ost Piet, Azinwi Ngwa C, Reuter Christiane, Bodis Stephan, Kaouthar Khanfir, Budach Volker, Aebersold Daniel M, Thalmann George N, Sumila Marcin, Biaggi-Rudolf Christine, Stalder Lukas, Hayoz Stefanie, Genitsch Vera, Zwahlen Daniel R, Hölscher Tobias, Gut Philipp, Guckenberger Matthias, Hildebrandt Guido, Müller Arndt-Christian, Putora Paul Martin, Papachristofilou Alexandros, Swiss Group for Clinical Cancer Research (SAKK)
Volumetric regression ratio of the primary tumor and metastatic lymph nodes after induction chemotherapy predicts overall survival in head and neck squamous cell carcinoma: a retrospective analysis
Elicin O, Giger R, Ghadjar P, Geretschlager A, Plasswilm L, Ambarcioglu P, Rauch D, Bromme J, Schmücking M, Aebersold D. Volumetric regression ratio of the primary tumor and metastatic lymph nodes after induction chemotherapy predicts overall survival in head and neck squamous cell carcinoma: a retrospective analysis. J BUON 2016; 21:175-81.
Jan 1, 2016Volumetric regression ratio of the primary tumor and metastatic lymph nodes after induction chemotherapy predicts overall survival in head and neck squamous cell carcinoma: a retrospective analysis
Jan 1, 2016J BUON 2016; 21:175-81
Elicin Olgun, Giger Roland, Ghadjar Pirus, Geretschlager Andreas, Plasswilm Ludwig, Ambarcioglu Pinar, Rauch Daniel, Bromme Jens, Schmücking Michael, Aebersold Daniel M
Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial
Stahel R, Caspar C, Eckhardt K, Schmid R, Aebersold D, Gautschi O, Nagel W, Töpfer M, Krayenbuehl J, Ribi K, Ciernik L, Mordasini C, Zippelius A, Riesterer O, Xyrafas A, Opitz I, Beyeler M, Ochsenbein A, Früh M, Cathomas R, Nackaerts K, Peters S, Mamot C, Weder W. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial. Lancet Oncol 2015; 16:1651-8.
Nov 2, 2015Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial
Nov 2, 2015Lancet Oncol 2015; 16:1651-8
Stahel Rolf A, Caspar Clemens B, Eckhardt Katrin, Schmid Ralph A, Aebersold Daniel M, Gautschi Oliver, Nagel Wolfgang, Töpfer Michael, Krayenbuehl Jerome, Ribi Karin, Ciernik Llja F, Mordasini Carlo, Zippelius Alfred, Riesterer Oliver, Xyrafas Alexandros, Opitz Isabelle, Beyeler Michael, Ochsenbein Adrian, Früh Martin, Cathomas Richard, Nackaerts Kristiaan, Peters Solange, Mamot Christoph, Weder Walter
Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience
Panje C, Panje T, Putora P, Kim S, Haile S, Aebersold D, Plasswilm L. Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience. Radiat Oncol 2015; 10:47.
Feb 22, 2015Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience
Feb 22, 2015Radiat Oncol 2015; 10:47
Panje Cédric, Panje Thierry, Putora Paul Martin, Kim Suk-Kyum, Haile Sarah, Aebersold Daniel M, Plasswilm Ludwig
Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10
Sassowsky M, Takacs I, Reuter C, Sumila M, Manser P, Ost P, Böhmer D, Pilop C, Aebersold D, Plasswilm L, Azinwi N, Zwahlen D, Gut P, Hölscher T, Hildebrandt G, Müller A, Najafi Y, Kohler G, Kranzbühler H, Guckenberger M, Ghadjar P. Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10. Int J Radiat Oncol Biol Phys 2013; 87:534-41.
Aug 22, 2013Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10
Aug 22, 2013Int J Radiat Oncol Biol Phys 2013; 87:534-41
Sassowsky Manfred, Takacs Istvan, Reuter Christiane, Sumila Marcin, Manser Peter, Ost Piet, Böhmer Dirk, Pilop Christiane, Aebersold Daniel M, Plasswilm Ludwig, Azinwi Ngwa C, Zwahlen Daniel R, Gut Philipp, Hölscher Tobias, Hildebrandt Guido, Müller Arndt-Christian, Najafi Yousef, Kohler Götz, Kranzbühler Helmut, Guckenberger Matthias, Ghadjar Pirus